{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:46:46Z","timestamp":1791978406314,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T00:00:00Z","timestamp":1425859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T00:00:00Z","timestamp":1425859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006986","name":"Legacy Heritage Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006986","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2015,5,1]]},"DOI":"10.15252\/embr.201439561","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T21:21:59Z","timestamp":1425936119000},"page":"590-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The alanine\u2010serine\u2010cysteine\u20101 (Asc\u20101) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission"],"prefix":"10.1038","volume":"16","author":[{"given":"Hazem","family":"Safory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Neame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Zubedat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Radzishevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Sason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Engelender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Avital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen","family":"H\u00fclsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Wolosker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,9]]},"reference":[{"key":"BFEMBR201439561_CR1","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/j.1460-2075.1988.tb03255.x","volume":"7","author":"CM Becker","year":"1988","unstructured":"Becker CM, Hoch W, Betz H (1988) Glycine receptor heterogeneity in rat spinal cord during postnatal development. EMBO J 7: 3717\u20133726","journal-title":"EMBO J"},{"key":"BFEMBR201439561_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0896-6273(03)00673-1","volume":"40","author":"J Gomeza","year":"2003","unstructured":"Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter DW, Laube B, Betz H (2003) Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40: 797\u2013806","journal-title":"Neuron"},{"key":"BFEMBR201439561_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ng1293-351","volume":"5","author":"R Shiang","year":"1993","unstructured":"Shiang R, Ryan SG, Zhu YZ, Hahn AF, O'Connell P, Wasmuth JJ (1993) Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat Genet 5: 351\u2013358","journal-title":"Nat Genet"},{"key":"BFEMBR201439561_CR4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/hmg\/11.7.853","volume":"11","author":"MI Rees","year":"2002","unstructured":"Rees MI, Lewis TM, Kwok JB, Mortier GR, Govaert P, Snell RG, Schofield PR, Owen MJ (2002) Hyperekplexia associated with compound hetero\u2010zygote mutations in the beta\u2010subunit of the human inhibitory glycine receptor (GLRB). Hum Mol Genet 11: 853\u2013860","journal-title":"Hum Mol Genet"},{"key":"BFEMBR201439561_CR5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1814","volume":"38","author":"MI Rees","year":"2006","unstructured":"Rees MI, Harvey K, Pearce BR, Chung SK, Duguid IC, Thomas P, Beatty S, Graham GE, Armstrong L, Shiang R et\u00a0al (2006) Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat Genet 38: 801\u2013806","journal-title":"Nat Genet"},{"key":"BFEMBR201439561_CR6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbrc.2006.07.080","volume":"348","author":"V Eulenburg","year":"2006","unstructured":"Eulenburg V, Becker K, Gomeza J, Schmitt B, Becker CM, Betz H (2006) Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun 348: 400\u2013405","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMBR201439561_CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.tig.2008.06.005","volume":"24","author":"RJ Harvey","year":"2008","unstructured":"Harvey RJ, Topf M, Harvey K, Rees MI (2008) The genetics of hyperekplexia: more than startle!. Trends Genet 24: 439\u2013447","journal-title":"Trends Genet"},{"key":"BFEMBR201439561_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.870120213","volume":"12","author":"ES Simon","year":"1997","unstructured":"Simon ES (1997) Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for alpha 1 and beta glycine receptor subunits. Mov Disord 12: 221\u2013228","journal-title":"Mov Disord"},{"key":"BFEMBR201439561_CR9","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1096\/fasebj.4.10.2165011","volume":"4","author":"CM Becker","year":"1990","unstructured":"Becker CM (1990) Disorders of the inhibitory glycine receptor: the spastic mouse. FASEB J 4: 2767\u20132774","journal-title":"FASEB J"},{"key":"BFEMBR201439561_CR10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nn.3615","volume":"17","author":"W Xiong","year":"2014","unstructured":"Xiong W, Chen SR, He L, Cheng K, Zhao YL, Chen H, Li DP, Homanics GE, Peever J, Rice KC et\u00a0al (2014) Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease. Nat Neurosci 17: 232\u2013239","journal-title":"Nat Neurosci"},{"key":"BFEMBR201439561_CR11","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1074\/jbc.275.13.9690","volume":"275","author":"Y Fukasawa","year":"2000","unstructured":"Fukasawa Y, Segawa H, Kim JY, Chairoungdua A, Kim DK, Matsuo H, Cha SH, Endou H, Kanai Y (2000) Identification and characterization of a Na(+)\u2010independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D\u2010 and L\u2010amino acids. J Biol Chem 275: 9690\u20139698","journal-title":"J Biol Chem"},{"key":"BFEMBR201439561_CR12","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1046\/j.1460-9568.2003.02966.x","volume":"18","author":"L Helboe","year":"2003","unstructured":"Helboe L, Egebjerg J, Moller M, Thomsen C (2003) Distribution and pharmacology of alanine\u2010serine\u2010cysteine transporter 1 (asc\u20101) in rodent brain. Eur J Neurosci 18: 2227\u20132238","journal-title":"Eur J Neurosci"},{"key":"BFEMBR201439561_CR13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainres.2005.06.039","volume":"1052","author":"X Xie","year":"2005","unstructured":"Xie X, Dumas T, Tang L, Brennan T, Reeder T, Thomas W, Klein RD, Flores J, O'Hara BF, Heller HC et\u00a0al (2005) Lack of the alanine\u2010serine\u2010cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice. Brain Res 1052: 212\u2013221","journal-title":"Brain Res"},{"key":"BFEMBR201439561_CR14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1046\/j.1471-4159.2000.0741434.x","volume":"74","author":"XF Wang","year":"2000","unstructured":"Wang XF, Cynader MS (2000) Astrocytes provide cysteine to neurons by releasing glutathione. J Neurochem 74: 1434\u20131442","journal-title":"J Neurochem"},{"key":"BFEMBR201439561_CR15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1471-4159.1970.tb00513.x","volume":"17","author":"RP Shank","year":"1970","unstructured":"Shank RP, Aprison MH (1970) The metabolism in\u00a0vivo of glycine and serine in eight areas of the rat central nervous system. J Neurochem 17: 1461\u20131475","journal-title":"J Neurochem"},{"key":"BFEMBR201439561_CR16","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1523\/JNEUROSCI.3836-12.2013","volume":"33","author":"D Rosenberg","year":"2013","unstructured":"Rosenberg D, Artoul S, Segal AC, Kolodney G, Radzishevsky I, Dikopoltsev E, Foltyn VN, Inoue R, Mori H, Billard JM et\u00a0al (2013) Neuronal D\u2010serine and glycine release via the Asc\u20101 transporter regulates NMDA receptor\u2010dependent synaptic activity. J Neurosci 33: 3533\u20133544","journal-title":"J Neurosci"},{"key":"BFEMBR201439561_CR17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/j.1460-9568.2007.05446.x","volume":"25","author":"AR Rutter","year":"2007","unstructured":"Rutter AR, Fradley RL, Garrett EM, Chapman KL, Lawrence JM, Rosahl TW, Patel S (2007) Evidence from gene knockout studies implicates Asc\u20101 as the primary transporter mediating d\u2010serine reuptake in the mouse CNS. Eur J Neurosci 25: 1757\u20131766","journal-title":"Eur J Neurosci"},{"key":"BFEMBR201439561_CR18","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.npp.1300480","volume":"29","author":"BK Yee","year":"2004","unstructured":"Yee BK, Chang DL, Feldon J (2004) The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse\u2010elicited reactivity in C57BL6 mice. Neuropsychopharmacology 29: 1865\u20131877","journal-title":"Neuropsychopharmacology"},{"key":"BFEMBR201439561_CR19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0014-2999(81)90195-3","volume":"71","author":"IP Lapin","year":"1981","unstructured":"Lapin IP (1981) Antagonism of L\u2010glycine to seizures induced by L\u2010kynurenine, quinolinic acid and strychnine in mice. Eur J Pharmacol 71: 495\u2013498","journal-title":"Eur J Pharmacol"},{"key":"BFEMBR201439561_CR20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/npp.2014.326","volume":"40","author":"N Kawai","year":"2015","unstructured":"Kawai N, Sakai N, Okuro M, Karakawa S, Tsuneyoshi Y, Kawasaki N, Takeda T, Bannai M, Nishino S (2015) The Sleep\u2010Promoting and Hypothermic Effects of Glycine are Mediated by NMDA Receptors in the Suprachiasmatic Nucleus. Neuropsychopharmacology 40: 1405\u20131416","journal-title":"Neuropsychopharmacology"},{"key":"BFEMBR201439561_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002130100763","volume":"156","author":"AM Ouagazzal","year":"2001","unstructured":"Ouagazzal AM, Jenck F, Moreau JL (2001) Drug\u2010induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity? Psychopharmacology 156: 273\u2013283","journal-title":"Psychopharmacology"},{"key":"BFEMBR201439561_CR22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mcn.2010.04.005","volume":"44","author":"AT Latal","year":"2010","unstructured":"Latal AT, Kremer T, Gomeza J, Eulenburg V, Hulsmann S (2010) Development of synaptic inhibition in glycine transporter 2 deficient mice. Mol Cell Neurosci 44: 342\u2013352","journal-title":"Mol Cell Neurosci"},{"key":"BFEMBR201439561_CR23","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1096\/fj.09-147967","volume":"24","author":"D Rosenberg","year":"2010","unstructured":"Rosenberg D, Kartvelishvily E, Shleper M, Klinker CM, Bowser MT, Wolosker H (2010) Neuronal release of D\u2010serine: a physiological pathway controlling extracellular D\u2010serine concentration. FASEB J 24: 2951\u20132961","journal-title":"FASEB J"},{"key":"BFEMBR201439561_CR24","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/nprot.2008.171","volume":"3","author":"PR Dunkley","year":"2008","unstructured":"Dunkley PR, Jarvie PE, Robinson PJ (2008) A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc 3: 1718\u20131728","journal-title":"Nat Protoc"},{"key":"BFEMBR201439561_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0922-4106(05)80040-9","volume":"207","author":"H Christensen","year":"1991","unstructured":"Christensen H, Fykse EM, Fonnum F (1991) Inhibition of gamma\u2010aminobutyrate and glycine uptake into synaptic vesicles. Eur J Pharmacol 207: 73\u201379","journal-title":"Eur J Pharmacol"},{"key":"BFEMBR201439561_CR26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3945\/jn.113.174417","volume":"143","author":"EV Abarinov","year":"2013","unstructured":"Abarinov EV, Beaudin AE, Field MS, Perry CA, Allen RH, Stabler SP, Stover PJ (2013) Disruption of shmt1 impairs hippocampal neurogenesis and mnemonic function in mice. J Nutr 143: 1028\u20131035","journal-title":"J Nutr"},{"key":"BFEMBR201439561_CR27","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1042\/BST20130220","volume":"41","author":"H Wolosker","year":"2013","unstructured":"Wolosker H, Radzishevsky I (2013) The serine shuttle between glia and neurons: implications for neurotransmission and neurodegeneration. Biochem Soc Trans 41: 1546\u20131550","journal-title":"Biochem Soc Trans"},{"key":"BFEMBR201439561_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00429-013-0645-0","volume":"220","author":"C Schnell","year":"2015","unstructured":"Schnell C, Shahmoradi A, Wichert SP, Mayerl S, Hagos Y, Heuer H, Rossner MJ, Hulsmann S (2015) The multispecific thyroid hormone transporter OATP1C1 mediates cell\u2010specific sulforhodamine 101\u2010labeling of hippocampal astrocytes. Brain Struct Funct 220: 193\u2013203","journal-title":"Brain Struct Funct"},{"key":"BFEMBR201439561_CR29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10545-011-9398-1","volume":"35","author":"JB Hennermann","year":"2012","unstructured":"Hennermann JB, Berger JM, Grieben U, Scharer G, Van Hove JL (2012) Prediction of long\u2010term outcome in glycine encephalopathy: a clinical survey. J Inherit Metab Dis 35: 253\u2013261","journal-title":"J Inherit Metab Dis"},{"key":"BFEMBR201439561_CR30","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","volume":"81","author":"AM Evans","year":"2009","unstructured":"Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E (2009) Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small\u2010molecule complement of biological systems. Anal Chem 81: 6656\u20136667","journal-title":"Anal Chem"},{"key":"BFEMBR201439561_CR31","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440\u20139445","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201439561_CR32","doi-asserted-by":"crossref","first-page":"e22059","DOI":"10.1371\/journal.pone.0022059","volume":"6","author":"A Avital","year":"2011","unstructured":"Avital A, Dolev T, Aga\u2010Mizrachi S, Zubedat S (2011) Environmental enrichment preceding early adulthood methylphenidate treatment leads to long term increase of corticosterone and testosterone in the rat. PLoS ONE 6: e22059","journal-title":"PLoS ONE"},{"key":"BFEMBR201439561_CR33","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1038\/tp.2014.82","volume":"4","author":"S Aga\u2010Mizrachi","year":"2014","unstructured":"Aga\u2010Mizrachi S, Cymerblit\u2010Sabba A, Gurman O, Balan A, Shwam G, Deshe R, Miller L, Gorodetsky N, Heinrich N, Tzezana O et\u00a0al (2014) Methylphenidate and desipramine combined treatment improves PTSD symptomatology in a rat model. Transl Psychiat 4: e447","journal-title":"Transl Psychiat"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201439561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.201439561","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.201439561\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.201439561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201439561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:49:41Z","timestamp":1779108581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.201439561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5,1]]}},"alternative-id":["BFEMBR201439561"],"URL":"https:\/\/doi.org\/10.15252\/embr.201439561","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,9]]},"assertion":[{"value":"10 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}